# STOCKHOLM 1.0
#=GF ID   SAA
#=GF AC   PF00277.22
#=GF DE   Serum amyloid A protein
#=GF PI   SAA_proteins; 
#=GF AU   Finn RD;0000-0001-8626-2148
#=GF SE   Prosite
#=GF GA   30.80 30.80;
#=GF TC   31.20 32.50;
#=GF NC   29.50 29.80;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -Z 75585367 -E 1000 HMM pfamseq
#=GF TP   Family
#=GF RN   [1]
#=GF RM   7504491
#=GF RT   Serum amyloid A (SAA): an acute phase protein and
#=GF RT   apolipoprotein.
#=GF RA   Malle E, Steinmetz A, Raynes JG;
#=GF RL   Atherosclerosis. 1993;102:131-146.
#=GF RN   [2]
#=GF RM   8188253
#=GF RT   Evolution of the serum amyloid A (SAA) protein superfamily.
#=GF RA   Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS;
#=GF RL   Genomics. 1994;19:228-235.
#=GF RN   [3]
#=GF RM   30852808
#=GF RT   Serum amyloid A levels are associated with polymorphic variants
#=GF RT   in the serum amyloid A 1 and 2 genes.
#=GF RA   Griffiths K, Maxwell AP, McCarter RV, Nicol P, Hogg RE,
#=GF RA   Harbinson M, McKay GJ;
#=GF RL   Ir J Med Sci. 2019;188:1175-1183.
#=GF RN   [4]
#=GF RM   30165816
#=GF RT   Serum amyloid A - a review.
#=GF RA   Sack GH Jr;
#=GF RL   Mol Med. 2018;24:46.
#=GF DR   INTERPRO; IPR000096;
#=GF DR   PROSITE; PDOC00762;
#=GF DR   PRINTS; PR00306;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   The serum amyloid A (SAA) proteins comprise a family of
#=GF CC   vertebrate amphipathic alpha-helical apolipoproteins that
#=GF CC   associate predominantly with high density lipoproteins (HDL)
#=GF CC   [1,2]. They play a role in the mobilisation of cholesterol for
#=GF CC   tissue repair and regeneration [3]. The synthesis of these
#=GF CC   proteins is greatly increased (as much as a 1000 fold) in
#=GF CC   inflammation, being a major acute phase reactant together with
#=GF CC   C-reactive protein. They act as cytokine-like proteins that are
#=GF CC   involved in cell-cell communication and in inflammatory,
#=GF CC   immunologic, neoplastic and protective pathways [4]. Prolonged
#=GF CC   elevation of plasma SAA levels, as in chronic inflammation,
#=GF CC   results in a pathological condition, called amyloidosis, which
#=GF CC   is characterised by the highly insoluble accumulation of SAA in
#=GF CC   several tissues. During chronic inflammation, SAA association
#=GF CC   with HDL can change its protein and lipid composition which
#=GF CC   abrogates the HDL anti-atherogenic properties, contributing to a
#=GF CC   pro-atherogenic state [3,4].
#=GF SQ   21
#=GS G5AK06_HETGA/22-130      AC G5AK06.1
#=GS F6X6T7_CALJA/24-132      AC F6X6T7.2
#=GS A0A2K6DYZ0_MACNE/22-130  AC A0A2K6DYZ0.1
#=GS SAA4_BOVIN/22-129        AC Q32L76.1
#=GS G1TGM2_RABIT/55-163      AC G1TGM2.2
#=GS F7F2J2_ORNAN/21-121      AC F7F2J2.2
#=GS F7FPF7_MONDO/26-127      AC F7FPF7.2
#=GS SAA2_RABIT/22-122        AC P22000.1
#=GS G3U2U4_LOXAF/22-122      AC G3U2U4.1
#=GS W5MIJ6_LEPOC/21-122      AC W5MIJ6.1
#=GS Q4SI54_TETNG/21-121      AC Q4SI54.1
#=GS Q642J9_DANRE/21-121      AC Q642J9.1
#=GS U3K998_FICAL/31-132      AC U3K998.1
#=GS A0L550_MAGMM/36-145      AC A0L550.1
#=GS E1VGC3_9GAMM/574-686     AC E1VGC3.1
#=GS Q12LF8_SHEDO/55-162      AC Q12LF8.1
#=GS A0A7M7HPP4_STRPU/36-137  AC A0A7M7HPP4.1
#=GS G1PYU8_MYOLU/22-130      AC G1PYU8.1
#=GS G3I251_CRIGR/20-120      AC G3I251.1
#=GS L9LAH9_TUPCH/326-426     AC L9LAH9.1
#=GS SAA_SHEEP/3-112          AC P42819.1
G5AK06_HETGA/22-130                 YSFFKEAAQGSWDMWRAYWNLQVASYPNSERYFHARGNYDAAQRGPGGVWAAKVLSNAGKYLQGISNRFYYGMSNYGS.ENIESNQKAEEWGRYGKDPNH..........FRPPGLPEKY
F6X6T7_CALJA/24-132                 ESSAGERSTGAGDMCRAYWDLMASNHQNSDRYFYARGNYDAAQRGPGGVWAAKVISRFRDYLQVFANYYLSGDSSSVL.EDLKSNQKAEEWGRSGKDPNR..........FRTDGLAKKY
A0A2K6DYZ0_MACNE/22-130             FSFFKEALQGAGDLGRAYWNVLTSSHQNSKRYFYAQGNYDAAERGPGGVWAAKLISSTRVYLQGFLDYYLFGNSSTVL.EDSKSNEKAEEWGRSGKDPDR..........FRPDGMPKND
SAA4_BOVIN/22-129                   YSFFKEAVQGASDLWRAYWDMRDANVQNSGRYFRARGNYEAAQRGPGGVWAAKIISNVGEYLQGFLYQIYLGDS.YGL.EDQVSNRRAEEWGRSGQDPDH..........FRPAGLPKKY
G1TGM2_RABIT/55-163                 FSFFKEAIQGAGDLFKSYWDMREANYQRSDRYFYARGNYEAAQRGPGGVWAAKVISNARGYLEDLFNRYYFGSSNHRL.EDSQSNRKAEDWGRSGKNPDH..........FRPSDLPEKY
F7F2J2_ORNAN/21-121                 MFPLQSLRPGSWDMWNAHSDMREVNFKNSDKYFHARGNYDAAKRGPGGAWAAEIISDGREFLQETF........GRGM.EDLLADQEANRHGRSGGDPNH..........CRPAGLDEKY
F7FPF7_MONDO/26-127                 ARFIKEAGQGAGDMWRAYWDMREANYKNSDKYFHARGNYDAAQRGPGGAWAAKVISDGREFLQGGS.......SGRGV.EDSRADQFANEWGRSGKDPNH..........FRPAGLDPKY
SAA2_RABIT/22-122                   FSFIGEAVRGAGDMWRAYSDMREANYINADKYFHARGNYDAAQRGPGGVWAAKVISDVREDLQRLM........GHGA.EDSMADQAANEWGRSGKDPNH..........FRPKGLPDKY
G3U2U4_LOXAF/22-122                 WSFIPEAVGGAWDMWRAYSDMKEANYIGADKYFHARGNYDAARRGPGGAWAAEVISNARERIQSLT........GHGD.EDTRADQEANKWGRSGKDPNH..........FRPRGLPDKY
W5MIJ6_LEPOC/21-122                 YMFPVEAARGAGDMWSAYDDMREANWKNSDKYFHARGNRDAASRGPGGKWAAEVISNAREWWQGSA.......SGRGH.EDTEADQEANRWGRDGGDLSK..........YRPKDLPEKY
Q4SI54_TETNG/21-121                 YKFPGQAVRGSHDMYRAYRDMRKANWKNSDKYFHARGNYDAAQRGPGGRWAAKVISDAREWAQQKT........GRGA.SDSAADQAANRWGRNGGNPNV..........YRPRGLPRRY
Q642J9_DANRE/21-121                 YRFPGEAAGGAKDMWRAYQHMKEANWKNSDKYFHARGNYEAAQRGPGGYWAAKVISDGREALQGLI........RRGN.SDAAADQEANLWGRNGGDPNK..........YRPKGLPIKY
U3K998_FICAL/31-132                 GQFVRDAAGGTRDMYRAYKDMREANYRGADKYFHARGNYDAARRGPGGAWAARVISDARENWQSRV.......SGRGA.EDTRADQEANRWGRSGGDPNR..........YRPRGLPSKY
A0L550_MAGMM/36-145                 VKHMGQAALGAADMAHEYGKMRHDNVQLSDKYHHCMANCRATSRGPGGHQAAETISHVRELYGTHV.......KGDPL.WDRRADEAANQHGRSGAGQGQSCKQ..VCSPYRVRGINPKY
E1VGC3_9GAMM/574-686                VDYTVGAIGGAADFVDNYGDMRDANTIGGDKYFHCKANCEAAQRGQGGQDAARCISDSREWFDQHW......PKNDPP.SASAADQVANLYGRTQGAENTGGNCQQICAPFRPNGLPSQY
Q12LF8_SHEDO/55-162                 VLNQRQWIGGAYDFFGNYRDMRDANTIGADKYFHCKANCEATKRGKGGESAACTISDSREWFDQHI.......KGDPA...SAADQAANIFGRSNASSPQSCSL..VCSAFRPNGLPQGY
A0A7M7HPP4_STRPU/36-137             GDFVSGAVRGAGDMWRSYSDMREANTIGADKYFHARGNYEASQRGSGGRFAARVISDAREGWQGGV.......SGRGA.KDTQADQEANRWGRNGGDPNR..........YRPAGLPDGY
G1PYU8_MYOLU/22-130                 FEFLGQAFDGAKDMWRAYSDMREANYKNSDKYFHARGNYDAAQRGPGGVWAAEVISDFREAYPRLTDLLKHGDSGHGL.EDSLADQEANRWGRSGKNPNY..........YRPPGLPDKY
G3I251_CRIGR/20-120                 LSFIGEAYLGAGDMWRAYSDMKEANWKNSDKYFHARGNYDAAQRGPGGVWAAEILSDARENIQMFM........GRGH.EDSLADQEANRWGRSGNDPNH..........YRPKGLPDKY
L9LAH9_TUPCH/326-426                LIFLREAGQGTKDIWRAYSDMKEANFKNSDKYFHARGNYDAAQRGPGGAWAAEVISNARENIQRLT........GHGA.EDSAADQAANEWGRSGKDPNH..........FRPAGLPDKY
SAA_SHEEP/3-112                     LSFLGEAYEGAKDMWRAYSDMREANFKGADKYFHARGNYDAAQRGPGGVWAAEVISNGREALQGITDPLFKGMTRDQVREDTKADQFANEWGRSGKDPNH..........FRPPGLPDKY
#=GC seq_cons                       hpFhtEAspGAtDMWRAYpDMREANapNSDKYFHARGNYDAAQRGPGGsWAAcVIScuREhlQshh.......pG+Gh.EDotADQcANcWGRSGtDPN+..........aRPsGLPcKY
